INTERVET UK PRODUCTION LIMITED
Get an alert when INTERVET UK PRODUCTION LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-27 (this month)
Last made up 2025-05-13
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£85M
+1.6% vs 2023
Employees
240
+2.6% vs 2023
Profit before tax
£3M
+113% vs 2023
Name history
Renamed 1 time since incorporation
- INTERVET UK PRODUCTION LIMITED 2001-01-02 → present
- HOECHST ROUSSEL VET LIMITED 1996-05-13 → 2001-01-02
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £48,014,000 | £54,450,000 | |
| Operating profit | £1,562,000 | £3,617,000 | |
| Profit before tax | £1,636,000 | £3,484,000 | |
| Net profit | -£2,193,000 | £1,362,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £114,490,000 | £111,591,000 | |
| Net assets | £83,429,000 | £84,791,000 | |
| Equity | £83,429,000 | £84,791,000 | |
| Average employees | 234 | 240 | |
| Wages | £12,336,000 | £12,318,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 3.3% | 6.6% | |
| Net margin | -4.6% | 2.5% | |
| Return on capital employed | 1.4% | 3.2% | |
| Current ratio | 3.76x | 4.20x | |
| Interest cover | 62.48x | 10.67x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Given the matters described above, the Directors believe that the Company has the resources required to settle all liabilities as they fall due for at least 12 months from the date of signing the financial statements and that no material uncertainties exist. Accordingly, the financial statements have been prepared on a going concern basis.”
Significant events
- “On 30 November 2023 it was announced that there was an intention to transfer the vaccine manufacturing operations and production from Milton Keynes, Newbury and Graveley (UK) to other MSD sites between 2027 and 2030.It is expected that the company will cease production by 31 December 2030.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 31 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CAN TEMUCIN, Ebru | Director | 2018-07-05 | Oct 1972 | Turkish |
| CASAGRANDE, Henrique Augusto | Director | 2026-01-31 | Mar 1977 | Brazilian,American |
| LITVIN, Dionna Kathleen | Director | 2023-10-31 | Aug 1970 | American |
Show 31 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOUW, Andreas Johannes Louis Maria | Secretary | 2005-04-18 | 2007-03-16 |
| BURWOOD, Alan Edward | Secretary | 2002-10-07 | 2005-04-18 |
| DAVIES, William Robert | Secretary | 1996-05-13 | 2002-10-07 |
| PLAYFORD, Richard | Secretary | 2007-03-16 | 2008-12-05 |
| VAN HEUMEN, Marcus | Secretary | 2008-12-05 | 2013-01-31 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1996-05-13 | 1996-05-13 |
| BATTISON, John Robert | Director | 2000-02-17 | 2002-04-01 |
| BOLCSKEI, Andras | Director | 2012-09-25 | 2015-10-01 |
| CASADY, Paul Stoughton | Director | 2002-04-01 | 2005-12-01 |
| COLLINS, Keith Robert | Director | 1996-06-28 | 2001-10-01 |
| COSTA, Andrea Frances | Director | 2014-12-11 | 2018-07-05 |
| DAVIES, William Robert | Director | 1996-05-13 | 1996-06-28 |
| DEMETRIOU, Michale Sotiris | Director | 1996-06-06 | 1996-06-28 |
| DORNAUER, Horst Werner Konrad, Dr | Director | 1996-06-28 | 1998-03-05 |
| EHREN, Stijn Michiel | Director | 2008-12-05 | 2011-12-13 |
| HAGGIS, Robert Arthur | Director | 1996-05-13 | 1996-06-28 |
| HALLAS, David Charles | Director | 2008-12-05 | 2012-09-25 |
| HARBERG JR., Allen | Director | 2013-01-31 | 2019-06-03 |
| HILADO, Maria Teresa | Director | 2008-12-05 | 2009-07-02 |
| KOEHLER, Steven Hubrig | Director | 2008-12-05 | 2011-07-22 |
| LANZ CANDURIN, Helene Tatiana | Director | 2024-08-01 | 2026-01-31 |
| MCCOY JR., Barry Lee | Director | 2019-06-03 | 2023-10-31 |
| MCDOWELL, Mark Andrew Charles | Director | 2011-12-13 | 2013-12-31 |
| MEISLOCH, Karsten Clemens | Director | 2012-02-10 | 2014-12-11 |
| MOEHLENBROCK, Jan | Director | 2017-01-24 | 2024-08-01 |
| READ, Peter Robert, Dr | Director | 1996-06-28 | 1999-11-26 |
| RICHARDS, Peter | Director | 1996-06-28 | 2000-01-31 |
| STOLP, Ruurd | Director | 2001-10-01 | 2008-12-05 |
| VAN HEUMEN, Marcus Joespha Maria | Director | 2012-02-10 | 2013-01-31 |
| VARVELLA VICENTE, Mauricio | Director | 2015-10-01 | 2017-01-24 |
| WETTERHAHN, Pieter Paulus | Director | 2005-12-01 | 2008-06-12 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Msd Animal Health Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 168 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-07 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-05 | AA | accounts | Accounts with accounts type full | |
| 2025-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-03 | AA | accounts | Accounts with accounts type full | |
| 2024-09-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-07 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-03 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-06 | AA | accounts | Accounts with accounts type full | |
| 2023-05-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-01 | AA | accounts | Accounts with accounts type full | |
| 2022-05-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-06 | AA | accounts | Accounts with accounts type full | |
| 2021-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-08-20 | AA | accounts | Accounts with accounts type full | |
| 2020-05-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2020-04-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2019-11-18 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+13.4%
£48,014,000 £54,450,000
-
Cash
—
Not reported
-
Net assets
+1.6%
£83,429,000 £84,791,000
-
Employees
+2.6%
234 240
-
Operating profit
+131.6%
£1,562,000 £3,617,000
-
Profit before tax
+113%
£1,636,000 £3,484,000
-
Wages
-0.1%
£12,336,000 £12,318,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers